|
1）El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003; 18: 387-93
|
|
|
|
2）Tack J, Masaoka T, Janssen P. Functional dyspepsia. Curr Opin Gastroenterol. 2011; 27: 549-57
|
|
|
|
|
|
3）Vakil N, Halling K, Ohlsson L, et al. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol. 2013; 108: 767-74
|
|
|
|
|
|
4）Matsuzaki J, Suzuki H, Asakura K, et al. Classification of functional dyspepsia based on concomitant bowel symptoms. Neurogastroenterol Motil. 2012; 24: 325-e164
|
|
|
|
|
|
5）Matsuzaki J, Suzuki H, Fukushima Y, et al. High frequency of overlap between functional dyspepsia and overactive bladder. Neurogastroenterol Motil. 2012; 24: 821-7
|
|
|
|
|
|
6）Wood JD. Chapter 12 Gastric Motor Integration. In: Granger DN, ed. Enteric Nervous Systems (The Brain-In-The-Gut). San Rafael: Morgan and Claypool life sciences. 2011. p. 83-9
|
|
|
|
|
|
7）Farré R, Vanheel H, Vanuytsel T, et al. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity. Gastroenterology. 2013; 145: 566-73
|
|
|
|
|
|
8）Fuhrer M, Vogelsang H, Hammer J. A placebo-controlled trial of an oral capsaicin load in patients with functional dyspepsia. Neurogastroenterol Motil. 2011; 23: 918-e397
|
|
|
|
|
|
9）Vanheel H, Farre R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013; 10: 142-9
|
|
|
|
|
|
10）Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2013; Mar 8 [Epub ahead of print]
|
|
|
|
|
|
11）Janssen P, Verschueren S, Ly HG, et al. Intragastric pressure during food intake: a physiological and minimally invasive method to assess gastric accommodation. Neurogastroenterol Motil. 2011; 23: 316-22, e153-4
|
|
|
|
|
|
12）Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013; 10: 168-74
|
|
|
|
|
|
13）Gwee KA, Teng L, Wong RK, et al. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2009; 21: 417-24
|
|
|
|
|
|
14）Kim SE, Park YS, Kim N, et al. Effect of Helicobacter pylori Eradication on Functional Dyspepsia. J Neurogastroenterol Motil. 2013; 19: 233-43
|
|
|
|
|
|
15）Suzuki H, Okada S, Hibi T. Proton-pump inhibitors for the treatment of functional dyspepsia. Therap Adv Gastroenterol. 2011; 4: 219-26
|
|
|
|
|
|
16）Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol. 2005; 100: 1477-88
|
|
|
|
|
|
17）Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007; 5: 178-85; quiz 140
|
|
|
|
|
|
18）Arai M, Matsumura T, Tsuchiya N, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2012; 59: 62-6
|
|
|
|
|
|
19）Altan E, Masaoka T, Farre R, et al. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol. 2012; 6: 533-44
|
|
|
|
|
|
20）Matsueda K, Hongo M, Tack J, et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012; 61: 821-8
|
|
|
|
|